J&J Drops $400M Deal For Takeda's Surgical Patch
Johnson & Johnson dropped its planned $400 million deal to buy a surgical patch business from Takeda Pharmaceuticals on Friday under pressure from the U.S. Federal Trade Commission and European enforcers....To view the full article, register now.
Already a subscriber? Click here to view full article